Empagliflozin-13C6
Empagliflozin-13C6 (BI 10773-13C6) is 13C labeled Empagliflozin. Empagliflozin (BI 107730 is a selective sodium glucose cotransporter-2 (SGLT-2) inhibitor with an IC50 of 3.1 nM for human SGLT-2[1].
Product Specifications
Product Name Alternative
BI 10773-13C6
UNSPSC
12352005
Target
Isotope-Labeled Compounds
Related Pathways
Others
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease; Cancer
Smiles
ClC1=C(C[13C]2=[13CH][13CH]=[13C](O[C@H]3CCOC3)[13CH]=[13CH]2)C=C([C@@H]4O[C@@H]([C@H]([C@@H]([C@H]4O)O)O)CO)C=C1
Molecular Formula
C17 13C6H27ClO7
Molecular Weight
456.87
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15227800 1 Vial
Lentiviral mouse Asrgl1 shRNA (UAS) - Lentiviral mouse Asrgl1 shRNA (UAS, iRFP) plasmid
Ask
View Details 